Andrographis recall: Cold and flu medicine recalled after allergic reaction spike
要点
- Cold and flu medicines containing andrographis have been recalled across Australia after the herb was linked to rising cases of anaphylaxis. The Therapeutic Goods Administration says these products will no longer be listed as low-risk.
- It reported a fatal case in June 2024. Several brands, including BioCeuticals Armaforce and Clinical ImmuneForce, are affected.
- The regulator has warned it will take action against retailers that have not removed the products from mid-October.
在 AU Now 应用中获取本地提醒和完整新闻
提醒、短讯和收藏的新闻——在 Google Play 免费下载。
说明
这是根据 PerthNow Local 报道生成的 AI 摘要，可能无法完全涵盖原文细节。点击上方“继续阅读”查看完整原文。
在 AU Now 应用中关注这条新闻
你所在区域的提醒、短讯和收藏的新闻——在 Google Play 免费下载。
评论
还没有评论，开始讨论吧。